孫博弘，山東羅欣藥業(yè)集團(tuán)股份有限公司執(zhí)行副總裁，曾任億騰生產(chǎn)運(yùn)營(yíng)副總裁，羅氏制藥（上海）生產(chǎn)運(yùn)營(yíng)總監(jiān)等職務(wù)，化學(xué)學(xué)士學(xué)位，交通大學(xué)EMBA，有著制藥行業(yè)超過(guò)19年的從業(yè)經(jīng)驗(yàn)，是醫(yī)藥生產(chǎn)和質(zhì)量管理領(lǐng)域的資深管理者。
?
他2016年5月加入羅欣，現(xiàn)就任集團(tuán)執(zhí)行副總裁，全面負(fù)責(zé)供應(yīng)鏈中心管理和國(guó)際業(yè)務(wù)，是羅欣與阿拉賓度合資公司項(xiàng)目的總負(fù)責(zé)人。帶著羅欣人傳遞健康的情懷和堅(jiān)持創(chuàng)新發(fā)展的理念，孫博弘先生帶領(lǐng)團(tuán)隊(duì)逐步開(kāi)啟了羅欣的國(guó)際化征程，致力于實(shí)現(xiàn)國(guó)外已上市或是在研的優(yōu)良藥品通過(guò)羅欣平臺(tái)得以進(jìn)入中國(guó)，惠及國(guó)內(nèi)患者，成為健康的傳遞者。
Samuel Sun, Executive VP of Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., with more than 19 years of experience in the pharmaceutical industry, is an expert in pharmaceutical production and quality management. Before joining Luoxin, Samuel acted as the VP in charge of production and operation at Yiteng, and Senior Director in production and operation at Roche Pharmaceutical (Shanghai).?
Samuel joined Luoxin Group since May, 2016. He is fully responsible for the management of supply chain center and international business. Meanwhile, Samuel is also the General Manager of the joint venture company between Luoxin and Aurobindo. Committed himself to expanding the concept of “Luoxin Pharmaceutical, Source of Health”, Samuel persists in innovation and has opened up Luoxin's road to internationalization, made great efforts in introducing high-quality drug products to domestic market for further contributions to the health of all patients of China!